New Delhi, November 3 (IANS): The World Health Organisation (WHO) on Wednesday granted Emergency Use Listing approval to India's indigenously-developed Covid vaccine, Bharat Biotech's Covaxin.
The Technical Advisory Group of World Health Organisation has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing risk-benefit assessment for global use of the vaccine.
Australia has recognized Bharat Biotech s Covaxin vaccine as a valid vaccine to establish the vaccination status of travellers coming inside the country.
MELBOURNE, Nov 1: Australia’s medicines and medical devices regulator on Monday formally recognised India’s Covaxin, a vaccine against the coronavirus as the country’s border was reopened for the first time in nearly 20 months. Hyderabad-based Bharat Biotech’s Covaxin, and AstraZeneca and Oxford University’s Covishield are the two widely used vaccines in India. Australia has already recognised Covishield. “Today, the Therapeutic Goods Administration (TGA) determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be […]
India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee which hopes to have a final recommendation to the WHO next week, a top official of the global health agency said on Thursday, stressing that the UN body "trusts" the Indian industry that manufactures high quality vaccines.